Fingerprint
Dive into the research topics of 'Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically